Skip to Content

Vectical FDA Approval History

FDA Approved: Yes (First approved January 23, 2009)
Brand name: Vectical
Generic name: calcitriol
Dosage form: Ointment
Company: Galderma Laboratories, L.P.
Treatment for: Psoriasis

Vectical Ointment is a Vitamin D analog indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older.

Development Timeline for Vectical

DateArticle
Feb  3, 2009ApprovalGalderma Wins FDA Approval for Vectical Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.